Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20655460 | 0.95 | PTGER4 (0.40) | STSPTGER4PRMT5WDR77CRHR1 | |
| SCHEMBL20655457 | 0.92 | STS (0.36) | STSCYP11B1CYP11B2PRMT5WDR77 | |
| SCHEMBL20648352 | 0.90 | PTGER4 (0.35) | PTGER4CYP11B1CYP11B2 | |
| SCHEMBL20655459 | 0.89 | STS (0.35) | STSPTGER4PRMT5WDR77CRHR1 | |
| SCHEMBL20655221 | 0.88 | PIK3CD (0.36) | PTGER4CYP11B2 | |
| SCHEMBL22985120 | 0.88 | ALOX5AP (0.39) | — | |
| SCHEMBL20654928 | 0.88 | CYP1A2 (0.36) | STS | |
| SCHEMBL20654942 | 0.87 | CYP1A2 (0.42) | — | |
| SCHEMBL20114589 | 0.87 | STS (0.35) | STSPTGER4CYP11B1CYP11B2PRMT5 | |
| SCHEMBL20792039 | 0.86 | PTGER4 (0.36) | PTGER4CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11005048-B2 | Organic molecules, in particular for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-05-11 | — | — | US | disclosed |
| EP-3530659-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-08-28 | — | — | EP | disclosed |
| US-20190019960-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190019960-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OR51E2, ORC3 | STS 2190/4885PTGER4 585/4885CYP11B1 1100/4885 |
| US-11005048-B2 | Organic molecules, in particular for use in optoelectronic devices | OR10J3, OR51E2, ORC3 | STS 2190/4885PTGER4 585/4885CYP11B1 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.